
浏览全部资源
扫码关注微信
1.成都中医药大学,成都 610075
2.成都中医药大学 附属医院,成都 610075
[第一作者] 姚德祎,在读硕士,从事中西医结合防治内科疾病的研究,E-mail: 2685391865@qq.com
*卢云,博士,主任医师,教授,硕士生导师,从事中西医结合急危重症的临床与研究,E-mail: luyun999@126.com
收稿日期:2019-06-27,
网络出版日期:2019-08-06,
纸质出版日期:2020-01-05
移动端阅览
姚德祎, 陈星, 卢云. 中风醒脑液对缺血性脑中风早期神经功能恢复的影响[J]. 中国实验方剂学杂志, 2020,26(1):104-109.
De-yi YAO, Xing CHEN, Yun LU. Effect of Zhongfeng Xingnao Liquid on Neurological Recovery of Patients with Ischemic Stroke at Early Recovery[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(1): 104-109.
姚德祎, 陈星, 卢云. 中风醒脑液对缺血性脑中风早期神经功能恢复的影响[J]. 中国实验方剂学杂志, 2020,26(1):104-109. DOI: 10.13422/j.cnki.syfjx.20192231.
De-yi YAO, Xing CHEN, Yun LU. Effect of Zhongfeng Xingnao Liquid on Neurological Recovery of Patients with Ischemic Stroke at Early Recovery[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(1): 104-109. DOI: 10.13422/j.cnki.syfjx.20192231.
目的:
2
探讨中风醒脑液对缺血性脑中风恢复早期气虚血瘀证患者神经功能恢复的影响及抗炎、神经保护和改善微循环机制。
方法:
2
将128例患者采用随机按数字表法分为对照组和观察组各64例。两组患者基础治疗,口服阿托伐他汀钙片,10 mg·d
-1
;口服阿司匹林肠溶片,100 mg·d
-1
;控制血压、血糖,结合现代康复训练。观察组口服中风醒脑液,25 mL/次,3次/d;对照组口服中风醒脑液模拟剂,25 mL/次,3次/d。两组疗程均连续治疗90 d。记录治疗后不同时点美国国立卫生院神经功能缺损(NIHSS)评分;进行治疗前后Barthel指数,改良Rankin量表,Brunel平衡量表(BBA),Fugl-Meyer量表(FMA),气虚血瘀证评分和中风专用生活质量量表(SS-QOL)评分;检测治疗前后脑源性神经营养因子(BDNF),肿瘤坏死因子-
α
(TNF-
α
),同型半胱氨酸(Hcy),血清胱抑素C(Cys-C),血小板聚集率(ADP),纤维蛋白原(FIB)水平。
结果:
2
观察组临床疗效优于对照组(
Z
=1.981,
P
<
0.05);观察组在治疗后不同时点NIHSS评分均低于对照组(
P
<
0.01);观察组Barthel指数,FMA,BBA,SS-QOL评分均高于对照组(
P
<
0.01),气虚血瘀证评分低于对照组(
P
<
0.01);观察组残疾程度轻于对照组(
Z
=1.932,
P
<
0.05);观察组运动障碍程度轻于对照组(
Z
=2.149,
P
<
0.05);观察组BDNF水平高于对照组(
P
<
0.01),TNF-
α
,Hcy,Cys-C,ADP和FIB水平均低于对照组(
P
<
0.01)。
结论:
2
在常规西医综合康复措施的基础上,中风醒脑液可促进脑梗死恢复期(气虚血瘀证)患者神经功能缺损修复,有利于患者的康复,提高了生活质量,并具有一定的抗炎、改善微循环和神经保护作用,疗效优于单纯的西医综合康复治疗。
Objective:
2
To discuss the effect of Zhongfeng Xingnao liquid on neurological recovery of patients of ischemic stroke with Qi deficiency and blood stasis syndrome at early recovery
and the mechanisms of anti-inflammation
neuroprotection and improvement of microcirculation.
Method:
2
One hundred and twenty-eight patients were randomly divided into control group (64 cases) and observation group (64 cases) by random number table. Both groups’ patients got atorvastatin
10 mg/days
aspirin enteric-coated tablets
100 mg/days
and control of blood pressure and blood sugar
and modern rehabilitation training. Patients in control group orally got Zhongfeng Xingnao liquid
25 mL/time
3 times/days. The course of treatment was 90 days. And before and after treatment
national institutes of health neurological deficiency (NIHSS)
Barthel index
improvement Rankin scale
brunel balance scale (BBA)
Fugl-Meyer scale (FMA)
Qi deficiency and blood stasis syndrome (SS-QOL) were scored. And levels of brain-derived neurotrophic factor (BDNF)
tumor necrosis factor-alpha (TNF-alpha)
homocysteine (Hcy)
serum cystatin C (Cys-C)
platelet aggregation rate (ADP) and fibrinogen (FIB) were detected.
Result:
2
The clinical efficacy in observation group was better than that in control group (
Z
=1.981
P
<
0.05). At different time points after treatment
scores of NIHSS and Qi deficiency and blood stasis syndrome were lower than those in control group (
P
<
0.05)
whereas scores of Barthel index
FMA
BBA and SS-QOL were higher than those in control group (
P
<
0.01). Degrees of disability and dyskinesia in observation group was lighter than those in control group (
Z
=1.932
P
<
0.05). Degree of dyskinesia was lighter than that in control group (
Z
=2.149
P
<
0.05). And level of BDNF was higher than that in control group (
P
<
0.01)
while levels of TNF-
α
Hcy
Cys-C
ADP and FIB were lower than those in control group (
P
<
0.01).
Conclusion:
2
In addition to the routine comprehensive rehabilitation measures of western medicine
Zhongfeng Xingnao liquid can promote recovery of nerve function defect of patients of cerebral infarction with Qi deficiency and blood stasis syndrome at convalescence
is beneficial for rehabilitation of patients and improving the quality of life
with certain effects in resisting inflammation
improving microcirculation and protecting nerves
and better efficacy than simple western medicine treatment.
中国中西医结合学会神经科专业委员会 . 中国脑梗死中西医结合诊治指南(2017) [J]. 中国中西医结合杂志 , 2018 , 38 ( 2 ): 136 - 145 .
娄飞 , 周莹 , 赵玲 , 等 . 培元通脑胶囊治疗缺血性中风恢复期神经功能缺损的康复效果及作用机制 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 17 ): 224 - 229 .
徐鹏 , 张冬梅 , 吕志国 , 等 . 补阳还五汤治疗缺血性中风恢复期疗效的系统评价 [J]. 世界科学技术—中医药现代化 , 2018 , 20 ( 11 ): 1911 - 1923 .
中华医学会神经病学分会 . 中国脑血管病诊治指南与共识 [M]. 北京 : 人民卫生出版社 , 2016 : 1 - 5 .
喻腾云 , 吴艳华 , 孙寒静 , 等 . 缺血性脑卒中中医病因病机的层次关系 [J]. 吉林中医药 , 2016 , 36 ( 4 ): 328 - 331 .
郭建文 , 张晓云 , 兰万成 , 等 . 陈绍宏教授“中风核心病机论” [J]. 天津中医药 , 2006 , 23 ( 1 ): 7 - 9 .
张怡 , 陈绍宏 , 张晓云 . 中风醒脑口服液结合康复训练早期干预缺血性脑卒中后运动功能障碍临床研究 [J]. 时珍国医国药 , 2014 , 25 ( 8 ): 1903 - 1904 .
袁晓慧 . 中风醒脑液复方与脑血管疾病相关性研究概况 [J]. 中医临床研究 , 2015 , 7 ( 34 ): 27 - 28 .
李宜为 . 中风醒脑液对急性缺血性脑卒中大鼠血脑屏障预保护作用研究 [D]. 成都 : 成都中医药大学 , 2018 .
桑德春 , 纪树荣 , 张缨 , 等 . Fugl-Meyer量表在社区脑卒中康复疗效评定中的应用 [J]. 中国康复医学杂志 , 2007 , 22 ( 3 ): 264 - 265 .
惠建荣 , 裴建 , 王院春 , 等 . 针刺干预中风专用生活质量量表的Rasch分析 [J]. 中国针灸 , 2013 , 33 ( 4 ): 363 - 366 .
王安安 , 李文娟 . 脑梗死恢复期中西医治疗进展 [J]. 中西医结合心脑血管病杂志 , 2016 , 14 ( 24 ): 2900 - 2902 .
李艳青 , 谢荃 , 张晓云 . 中风醒脑液对体外培养缺血再灌注PC-12细胞SOD活性及MDA含量变化的影响 [J]. 中国中医急症 , 2013 , 22 ( 11 ): 1821 - 1822,1829 .
赵刚 , 张见平 , 董卫卫 , 等 . 康复运动佐用益气活血方治疗对脑梗死恢复期患者神经功能缺损及血清BDNF的影响 [J]. 临床误诊误治 , 2018 , 31 ( 10 ): 82 - 85 .
E Hakimizadeh , A Shamsizadeh , A Roohbakhsh , et al . Inhibition of TRPV1 confers neuroprotection, reduces TNF- α and increases IL-10 in a rat stroke model [J]. Fundam Clin Pharmacol , 2017 , 31 ( 4 ): 420 - 428 .
舒建中 , 唐军 , 李陈瑜 , 等 . 解郁安神颗粒合盐酸帕罗西汀片治疗缺血性脑中风后抑郁症的临床分析 [J]. 中国实验方剂学杂志 , 2016 , 22 ( 13 ): 177 - 181 .
Z SHI , Y GUAN , Y R HUO , et al . Elevated total homocysteine levels in acute ischemic stroke are associated with long-term mortality [J]. Stroke , 2015 , 46 ( 9 ): 2419 - 2425 .
D T Winovich , W T Longstreth , A M Arnold , et al . Factors associated with ischemic stroke survival and recovery in older adults [J]. Stroke , 2017 , 48 ( 7 ): 1818 - 1823 .
0
浏览量
18
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621